Lens On The Scientific Market
Key findings from our industry experts.
Pay Invoice
Latest Blogs
-
NAMs Shift from Policy to Practice: What Life Science R&D Suppliers Need to Know in 2026
March 11, 2026 3:51 pm
Sitemap
Your Data and Privacy
About Us
BioInformatics, part of the Science and Medicine Group, is the leading research and advisory firm serving the life science and diagnostic industries. Our expertise includes primary quantitative and qualitative research in addition to secondary research and published reports. We own a proprietary, international community of more than 55,000 scientists and biomedical researchers to provide insights that grow businesses and move markets. Our multi-disciplinary team is comprised of industry veterans, market research experts, and survey statisticians.
Digital Marketing to Life Scientists in 2016
Scientists were among the first to use the Internet to publish and share information and to communicate with each other. The suppliers of lab instruments and consumables were among the first to identify their customer’s digital behavior and respond with email marketing to direct them to the earliest online catalogs and e-commerce systems. This evolution […]
Social Media and Life Scientists in 2016
Social media continues to evolve and life science suppliers are challenged to keep up with the medium and demonstrate a Return On Investment. Clearly marketing should focus on wherever customers gather and the results of this survey show scientists use many forms of social media in their personal and professional lives. Learn more about our latest […]
Digital Marketing to Life Scientists in 2016
Scientists were among the first to use the Internet to publish and share information and to communicate with each other. The suppliers of lab instruments and consumables were among the first to identify their customer’s digital behavior and respond with email marketing to direct them to the earliest online catalogs and e-commerce systems. This evolution […]
How scientists really feel about the Millipore-Sigma merger
On November 18th, 2015, Germany’s Merck KGaA announced the completion of its $17 billion acquisition of Sigma-Aldrich, following approval from the European Commission. This month, we invited over 300 global customers of both companies and asked for their reaction to the mega merger. We invite you to download our complimentary report and discover customer sentiments, […]
What are the real possibilities for genome editing and CRISPR/Cas9?
BioInformatics has become the preeminent leader in the market for commercial and VOC data, analysis and industry-wide opinions about the hottest topic in the life sciences: CRISPR/Cas9 technology. (See our complimentary report The CRISPR Toolbox.) In the 2016 Life Science Global Lab Funding & Budget Outlook, we polled members of The Science Advisory Board and asked: “What do […]
The Next Big Thing
There’s probably no better way to predict the future of science than to crowdsource opinions from hundreds of global scientific researchers. So, that’s what we did! In the 2016 Life Science Global Lab Funding & Budget Outlook, we polled members of The Science Advisory Board and asked: “What do you think is the most exciting technological […]
The CRISPR/Cas9 Toolbox
Following our latest publication, The 2016 Market for CRISPR/Cas9 Genome Editing Products, released in June 2015 on the Interactive Market Intelligence platform, a follow-up questionnaire was sent to The Science Advisory Board to quantify how the emergence of CRISPR/Cas9 technology is impacting the use of traditional tools and techniques. The questionnaire was fielded between July […]
Part II: CRISPR’s impact on current tools/techniques
Diving into Part II of the CRISPR Workflow series, we are exploring how our panel believes feel that current tools, techniques and methods will be impacted due to the emergence of CRISPR technology in their labs. We know that while many of our clients are seeking preeminence in newly formed product lines for CRISPR/Cas9 kits and consumables, the […]
Part I: Panel suggestions for improving the CRISPR workflow
Following the insights gained from our The Market for CRISPR/Cas9 Genome Editing Products report (released June 2015 on the Interactive Market Intelligence platform), we fielded a follow-up questionnaire to our expert panel to quantify how the emergence of CRISPR is impacting the use of traditional tools and techniques. The following insights are Part One of a series […]
Know Your Net Promoter Score
BioInformatics has announced three significant upgrades to the Interactive Market Intelligence experience. In addition to much better on-site performance and faster page loading speeds, we have added Net Promoter Score and a Content section, which contains a summarized export and full questionnaire of the report. IMI, launched this year, has transformed the way life science market data […]